Solid Tumors
Beamion PANTUMOR-1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficacy and safety of oral zongertinib (BI 1810631) for the treatment of selected HER2-mutated or overexpressed/amplified solid tumours (1479-0009)
- Details
ClinicalTrials.gov ID:
NCT06581432
Diagnosis Type:
NA
USOR Number:
- Address
,
P: